BSE Circulars (21214)
Bombay Stock Exchange circulars covering trading rules, listing requirements, compliance guidelines, market operations, and regulatory changes for market participants.
| Date | Circular | Tags | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
BSE announces listing of privately placed debt securities from multiple issuers including Manappuram Finance, Keertana Finserv, and others … | |||||||||||||||
BSE announces listing of privately placed debt securities from multiple issuers including Manappuram Finance, Keertana Finserv, and others effective January 1, 2026.
| |||||||||||||||
The Wealth Company Gold ETF units are listed and admitted to trading on BSE in the E Group effective January 2, 2026, tracking domestic gold … | |||||||||||||||
The Wealth Company Gold ETF units are listed and admitted to trading on BSE in the E Group effective January 2, 2026, tracking domestic gold prices.
| |||||||||||||||
The Wealth Company Gold ETF, an open-ended scheme tracking domestic gold prices, listed on BSE with 785,271 units effective January 2, 2026. | |||||||||||||||
The Wealth Company Gold ETF, an open-ended scheme tracking domestic gold prices, listed on BSE with 785,271 units effective January 2, 2026.
| |||||||||||||||
The Wealth Company Gold ETF, an open-ended scheme tracking domestic gold prices, listed on BSE in E Group with 785,271 units effective … | |||||||||||||||
The Wealth Company Gold ETF, an open-ended scheme tracking domestic gold prices, listed on BSE in E Group with 785,271 units effective January 2, 2026.
| |||||||||||||||
Limited review report for Achyut Healthcare Limited's unaudited financial results for half year ended September 30, 2025, prepared as part … | |||||||||||||||
Limited review report for Achyut Healthcare Limited's unaudited financial results for half year ended September 30, 2025, prepared as part of the company's migration from BSE SME to Mainboard platform.
| |||||||||||||||
Limited review report for Achyut Healthcare Limited's unaudited financial results for the half year ended September 30, 2025, submitted as … | |||||||||||||||
Limited review report for Achyut Healthcare Limited's unaudited financial results for the half year ended September 30, 2025, submitted as part of the company's migration from BSE SME to Mainboard platform.
| |||||||||||||||
Limited review report for Achyut Healthcare Limited's unaudited financial results for half year ended September 30, 2025, in connection with … | |||||||||||||||
Limited review report for Achyut Healthcare Limited's unaudited financial results for half year ended September 30, 2025, in connection with migration from SME to Mainboard platform.
| |||||||||||||||
Schedule of activities for the Offer to Buy (Acquisition Window/Takeover) of Oscar Global Ltd shares, scheduled from January 2-15, 2026, … | |||||||||||||||
Schedule of activities for the Offer to Buy (Acquisition Window/Takeover) of Oscar Global Ltd shares, scheduled from January 2-15, 2026, with offer price of Rs. 12.15 per share for up to 8,58,000 equity shares.
| |||||||||||||||
Schedule of activities for takeover offer of OSCAR GLOBAL LTD shares from January 2-15, 2026, with offer price of Rs. 12.15 per share for up … | |||||||||||||||
Schedule of activities for takeover offer of OSCAR GLOBAL LTD shares from January 2-15, 2026, with offer price of Rs. 12.15 per share for up to 8,58,000 equity shares.
| |||||||||||||||
BSE announces the schedule of activities for the Offer to Buy – Acquisition Window (Takeover) of shares of OSCAR GLOBAL LTD, scheduled from … | |||||||||||||||
BSE announces the schedule of activities for the Offer to Buy – Acquisition Window (Takeover) of shares of OSCAR GLOBAL LTD, scheduled from January 2, 2026 to January 15, 2026.
| |||||||||||||||